Arcturus Therapeutics Holdings Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | 103.5% | 104.2% | 100.2% | 108.1% | 33.5% | 166.5% | 177.1% | 116.0% | 64.0% | 168.4% | 71.6% | 212.6% | 404.1% | 299.2% | 342.1% | 758.6% | 1,000.3% | 2,353.1% | 2,282.8% | 1,862.9% | 530.4% | 856.1% | 141.0% | 281.9% | 16.8% | 64.5% | 35.6% | 1.8% | 3.2% | 2.8% | 2.0% | 2.3% | 3.9% | – | – | 19.5% | 22.1% | 107.9% | – | – | |
| – | 12.0% | -4.2% | -0.2% | -8.1% | 66.5% | -66.5% | -77.1% | -16.0% | 36.0% | -68.4% | 28.4% | -112.6% | -304.1% | 100.0% | 100.0% | 100.0% | -900.3% | -2,253.1% | -2,182.8% | -1,762.9% | -430.4% | -756.1% | -41.0% | -181.9% | 83.2% | 35.5% | 64.4% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 80.5% | 100.0% | -7.9% | 100.0% | 83.2% | |
| – | 21.8% | 53.6% | 38.4% | 32.1% | 87.4% | 166.5% | 177.1% | 116.0% | 64.0% | 168.4% | 71.6% | 212.6% | 404.1% | 299.2% | 342.1% | 758.6% | 1,085.2% | 2,353.1% | 2,282.8% | 1,862.9% | 563.2% | 856.1% | 141.0% | 281.9% | 16.8% | 64.5% | 500.7% | 117.8% | 146.0% | 164.3% | 127.6% | 100.8% | 208.5% | 118.8% | 120.7% | 135.6% | 794.4% | 3,430.3% | 591.9% | 362.1% | |
| – | 6.3% | 30.7% | 55.6% | 49.9% | 20.4% | 215.4% | 345.1% | 111.3% | 45.4% | 81.2% | 34.0% | 117.0% | 141.2% | 158.4% | 190.4% | 238.8% | 403.7% | 458.1% | 501.8% | 445.6% | 186.5% | 204.6% | 40.6% | 93.4% | 7.4% | 17.1% | 125.7% | 30.8% | 49.9% | 45.6% | 26.8% | 34.2% | 59.0% | 38.5% | 42.2% | 60.6% | 455.3% | 1,551.6% | 371.4% | 188.6% | |
| – | 29.9% | 94.6% | 101.6% | 87.7% | 101.1% | 381.9% | 522.1% | 227.3% | 109.4% | 249.6% | 105.6% | 329.5% | 60.3% | 457.6% | 532.5% | 997.5% | 488.6% | 458.1% | 501.8% | 445.6% | 219.3% | 204.6% | 40.6% | 93.4% | 7.4% | 17.1% | 590.9% | 144.5% | 172.9% | 193.3% | 146.0% | 127.7% | 259.0% | 157.3% | 147.4% | 176.8% | 1,116.1% | 4,874.1% | 963.3% | 516.6% | |
| – | -29.9% | -94.6% | -101.6% | -87.7% | -1.1% | -281.9% | -422.1% | -127.3% | -9.4% | -149.6% | -5.6% | -229.5% | -364.5% | -357.6% | -432.5% | -897.5% | -1,388.8% | -2,711.1% | -2,684.7% | -2,208.5% | -649.7% | -960.7% | -81.5% | -275.3% | 75.8% | 18.4% | -526.4% | -44.5% | -72.9% | -93.3% | -46.0% | -27.7% | -159.0% | -57.3% | -47.4% | -96.3% | -1,016.1% | -4,882.0% | -863.3% | -433.4% | |
| – | 3.0% | 3.3% | 0.9% | 1.9% | 4.2% | 0.1% | 5.1% | 4.4% | 2.4% | 4.7% | 2.0% | 6.2% | 8.1% | 9.6% | 8.4% | 8.1% | 8.5% | 25.7% | 35.5% | 29.2% | 12.2% | 13.7% | 2.7% | 5.7% | 0.5% | 0.9% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | |
| – | -29.0% | -91.3% | -97.8% | -76.7% | -9.1% | -277.6% | -417.0% | -124.2% | -13.3% | -158.3% | -6.7% | -224.0% | -370.2% | -369.5% | -442.0% | -900.3% | -1,389.8% | -2,649.1% | -2,727.7% | -2,219.3% | -667.3% | -975.8% | -79.6% | -263.8% | 74.0% | 63.3% | -494.1% | -35.3% | -45.6% | -81.1% | -37.8% | -18.3% | -142.9% | -47.9% | -37.4% | -78.4% | -943.9% | -4,420.3% | -803.8% | -391.9% | |
| – | 0.0% | 0.3% | 0.3% | 0.8% | -0.4% | 4.3% | 0.0% | -5.8% | 4.0% | -2.0% | 0.9% | 1.7% | 15.8% | -7.3% | 4.1% | -9.4% | 7.6% | 84.3% | -4.7% | -0.8% | 1.0% | 15.1% | 2.2% | -5.7% | 0.8% | 0.1% | 5.5% | 2.1% | 1.0% | 1.1% | -0.3% | -0.6% | 0.0% | -57.3% | 0.0% | -97.3% | -0.1% | – | – | – | |
| – | -29.1% | -91.6% | -98.1% | -77.5% | -8.7% | -277.6% | -417.0% | -124.2% | -13.3% | -158.3% | -6.7% | -224.0% | -370.2% | -369.5% | -442.0% | -900.3% | -1,389.8% | -2,649.1% | -2,727.7% | -2,219.3% | -667.3% | -975.8% | -79.6% | -263.8% | 73.2% | 63.2% | -499.6% | -37.4% | -46.7% | -82.3% | -37.4% | -17.8% | -142.9% | -47.9% | -37.5% | -78.4% | -943.8% | -4,420.3% | -803.8% | -391.9% | |
| – | -29.0% | -87.5% | -25.7% | -71.5% | -0.3% | -272.9% | -416.1% | -122.6% | -5.3% | -149.6% | 0.6% | -215.9% | -440.2% | -353.0% | -424.5% | -882.8% | -1,376.8% | -2,696.7% | -2,677.9% | -2,178.3% | -649.7% | -957.8% | -75.7% | -254.9% | 74.9% | 65.0% | -487.1% | -33.4% | -42.4% | -78.4% | -35.8% | -16.0% | -139.0% | -45.2% | -34.3% | -74.0% | -653.7% | -4,312.5% | -803.8% | -348.4% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.